Skip to main content

Innovex International, Inc.

For the period ended Sep 30, 2025. Filed Nov 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 4, 2025

INVX$25.13+2.9%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

(in thousands, except share and par value amounts)September 30,2025December 31,2024
Assets
Current assets
Cash and restricted cash$163,374$73,278
Trade receivables, net of allowance of $20,225 and $63,875 at September 30, 2025 and December 31, 2024, respectively220,408239,506
Contract assets2,9865,062
Inventories275,197271,173
Assets held for sale9544,749
Prepaid expenses and other current assets47,43347,623
Total current assets710,352641,391
Noncurrent assets
Property and equipment, net158,685190,786
Right of use assets – operating54,74554,873
Goodwill95,38460,176
Intangibles, net120,479108,363
Deferred tax asset, net104,132134,540
Other long-term assets10,1337,354
Total noncurrent assets543,558556,092
Total assets$1,253,910$1,197,483
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$66,633$65,201
Accrued expenses45,68060,593
Operating lease liabilities12,78510,547
Contract liabilities10,28613,463
Current portion of long-term debt and finance lease obligations6,31610,467
Other current liabilities7,0102,387
Total current liabilities148,710162,658
Noncurrent liabilities
Long-term debt and finance lease obligations20,09024,901
Operating lease liabilities43,28745,153
Deferred income taxes619624
Other long-term liabilities2,2505,991
Total noncurrent liabilities66,24676,669
Total liabilities$214,956$239,327
Commitments and contingencies (Note 17)
Stockholders’ equity
Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued)$—$—
Common stock: $0.01 par value, 200,000,000 and 100,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; 68,924,402 and 69,178,263 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively689692
Additional paid-in capital763,164755,077
Accumulated other comprehensive income3,795(8,863)
Retained earnings271,306211,250
Total stockholders’ equity$1,038,954$958,156
Total liabilities and stockholders’ equity$1,253,910$1,197,483
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.